Amazon to stock Narcan opioid overdose reversal drug at warehouses, WSJ reports

Amazon (AMZN) will begin stocking opioid overdose medication naloxone, sometimes known by the brand name Narcan, across its warehouse network, The Wall Street Journal’s Sebastian Herrera reports. The move will make Amazon one of the biggest U.S. employers to respond to government pressure to make overdose medicine more available in the workplace, the report notes. The ecommerce giant will begin with its large fulfillment center warehouses and then supply the drugs to its delivery centers, air hubs and other facilities, and could eventually stock corporate offices with Narcan, which is made by Emergent BioSolutions (EBS). “We need to be doing something,” said Anthony Harris, Amazon’s global medical director. “The right decision for us is to provide this intervention to help deal with the epidemic.”